U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111390) titled 'Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)' on Aug. 01.
Brief Summary: This pilot study evaluates the feasibility, safety, and preliminary efficacy of home-based 60Hz intermittent light therapy in adults with a major depressive episode (MDE). Participants will be randomized in a 2:1 ratio to receive either active or sham 60Hz intermittent light stimulation for 30 minutes daily (Monday through Friday) over three weeks. The light is delivered through a wearable headset. Clinical assessments will be conducted remotely at baseline, mid-point, post-treatment, and follow-up to measure chan...